This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

New Once-daily Treatment for Type 2 Diabetes

Posted: Wednesday, July 15, 2009

A new treatment for Type 2 diabetes may soon be a reality in the U.S.. Liraglutide (Victoza), a once-daily injectable treatment for Type 2 diabetes, is pharmaceutical company Novo Nordisk's latest brain child and has been approved by the E.U.

From the Glucagon-like peptide-1 (GLP-1) family of drugs, it can be taken any time of day, irrespective of meals. It helps to control Type 2 diabetes by stimulating the release of insulin when blood glucose levels are too high.

In addition, makers claim liraglutide aids weight loss by making you feel more full and delaying the rate at which your stomach empties. Studies have also shown that the drug can reduce blood pressure and improve the function of beta cells -- the cells that produce insulin in the pancreas.

Cathy Moulton, Care Advisor at leading health charity Diabetes UK, said, "Liraglutide widens the choice of treatments for people with Type 2 diabetes that not only offer improved blood glucose control but also aid weight loss. In addition, research has shown that this treatment has a positive effect on blood pressure levels."

Source: Diabetes In Control: Diabetes UK